Tomnya had everything going for it; a novel approach to pain and good Phase II trial results, but Tonix’s reformulation of Flexeril that was expected to help with both sleep and pain tanked in its critical Phase III trial. Check out what happened with it, and...
In a first for ME/CFS, at the HHV6 Conference in Paris Dr. Peterson reported a retrospective study indicated a little used anti-herpesvirus drug called Vistide significantly helped 70% of severely ill patients – with many able to return to work. With this...
Summer Donation Drive
Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information
The Big Map
Support Health Rising
BECOME A RECURRING DONOR
GIVE A ONE-TIME DONATION
HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT
Shopping on Amazon.com For HR
Help keep Health Rising on the Web! Support us in our quickie summer fundraising drive. Click here for more.